FRANK E THOMAS Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for FRANK E THOMAS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of FRANK E THOMAS. FRANK E THOMAS is EVP, Chief Operating Officer in AMAG PHARMACEUTICALS INC. ($AVM) and President & COO in AMAG PHARMACEUTICALS INC. ($AVM) and VP, Finance & CFO in ESPERION THERAPEUTICS INC/MI ($ESPR) and Director in ZAFGEN, INC. ($ZFGN) and Director in Spero Therapeutics, Inc. ($SPRO) and See Remarks in Orchard Therapeutics plc ($ORTX).

Latest Insider Trading Transactions of FRANK E THOMAS

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AVM, ESPR, LRMR, ORTX, SPRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 01 2021ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksOption ExerciseM2.4410,00024,400426,185
Feb 01 2021ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksBuyM2.4410,00024,40042,08132.1 K to 42.1 K (+31.17 %)
Jan 12 2021ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksPayment of ExerciseF6.723,70624,90432,08135.8 K to 32.1 K (-10.36 %)
Jan 12 2021ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksGrantA0.0010,667035,78725.1 K to 35.8 K (+42.46 %)
Jan 12 2021ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksPayment of ExerciseF6.723,70624,90432,08135.8 K to 32.1 K (-10.36 %)
Jan 12 2021ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksGrantA0.0010,667035,78725.1 K to 35.8 K (+42.46 %)
Jan 06 2021SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA17.931,31423,5601,314
Oct 27 2020SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA13.527,500101,4007,500
Sep 30 2020ZFGNLarimar Therapeuti ...THOMAS FRANK EDirectorOption ExerciseA11.9016,600197,54016,600
Jun 15 2020ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksOption ExerciseM2.4410,00024,400436,185
Jun 15 2020ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksBuyM2.4410,00024,40025,12015.1 K to 25.1 K (+66.14 %)
Apr 03 2020ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksOption ExerciseA7.05150,0001,057,500150,000
Jan 06 2020SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA9.872,70426,6882,704
Jan 06 2020ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksOption ExerciseA13.58200,0002,716,000200,000
Jun 27 2019ZFGNZAFGEN, INC.THOMAS FRANK EDirectorOption ExerciseA1.2527,00033,75027,000
Jun 05 2019SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA10.676,07364,7996,073
Jun 07 2018ZFGNZAFGEN, INC.THOMAS FRANK EDirectorOption ExerciseA6.7920,000135,80020,000
Jun 06 2018SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA11.546,07370,0826,073
Jun 23 2017ZFGNZAFGEN, INC.THOMAS FRANK EDirectorOption ExerciseA3.9514,50057,27514,500
Feb 27 2017AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOOption ExerciseA23.7530,000712,50030,000
Feb 27 2017AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOGrantA0.0012,0000138,195126.2 K to 138.2 K (+9.51 %)
Feb 27 2017AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOGrantA0.0012,0000126,195114.2 K to 126.2 K (+10.51 %)
Jul 01 2016ZFGNZAFGEN, INC.THOMAS FRANK EDirectorOption ExerciseA5.9912,00071,88012,000
Mar 01 2016AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOOption ExerciseA25.1840,0001,007,20040,000
Mar 01 2016AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOGrantA0.0017,0000114,19597.2 K to 114.2 K (+17.49 %)
Mar 01 2016AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOPayment of ExerciseF26.2851513,53497,19597.7 K to 97.2 K (-0.53 %)
Mar 01 2016AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOPayment of ExerciseF27.0145812,37197,71098.2 K to 97.7 K (-0.47 %)
Mar 01 2016AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOPayment of ExerciseF27.011,36136,76198,16899.5 K to 98.2 K (-1.37 %)
Mar 01 2016AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOPayment of ExerciseF27.017,417200,33399,529106.9 K to 99.5 K (-6.94 %)
Aug 21 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOPayment of ExerciseF61.712,363145,821106,946109.3 K to 106.9 K (-2.16 %)
Aug 07 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOOption ExerciseM14.9115,000223,65045,000
Aug 07 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOSellS66.8515,0001,002,750109,309124.3 K to 109.3 K (-12.07 %)
Aug 07 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOBuyM14.9115,000223,650124,309109.3 K to 124.3 K (+13.72 %)
Jul 15 2015ZFGNZAFGEN, INC.THOMAS FRANK EDirectorOption ExerciseA37.1512,000445,80012,000
Jun 08 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOSellS69.767,996557,801109,309117.3 K to 109.3 K (-6.82 %)
Jun 08 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EPresident & COOSellS69.2712,004831,517117,305129.3 K to 117.3 K (-9.28 %)
Mar 05 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EEVP, Chief Operatin ...Payment of ExerciseF49.704,279212,666129,309133.6 K to 129.3 K (-3.20 %)
Feb 27 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EEVP, Chief Operatin ...Option ExerciseA49.4625,0001,236,50025,000
Feb 27 2015AVMAMAG PHARMACEUTICA ...THOMAS FRANK EEVP, Chief Operatin ...GrantA0.0012,5000133,588121.1 K to 133.6 K (+10.32 %)
Feb 12 2004ESPRESPERION THERAPEUT ...THOMAS FRANK EVP, Finance & CFOOption ExerciseD0.00102,20100
Feb 09 2004ESPRESPERION THERAPEUT ...THOMAS FRANK EVP, Finance & CFOOption ExerciseM0.0046,7990102,201
Feb 09 2004ESPRESPERION THERAPEUT ...THOMAS FRANK EVP, Finance & CFOSellU35.0048,7781,707,230048.8 K to 0 (-100.00 %)
Feb 09 2004ESPRESPERION THERAPEUT ...THOMAS FRANK EVP, Finance & CFOBuyM0.0046,799048,7782 K to 48.8 K (+2,364.78 %)

Page:   1